PHARMAC is seeking feedback on a proposal relating to a provisional agreement with Douglas Pharmaceuticals Limited for the supply of glyceryl trinitrate oral spray (“Nitrolingual Pump Spray”) and a 25 mg azathioprine tablets (“Azamun”).
In summary, this proposal would result in:
For more details, go to: http://www.pharmac.health.nz/news/consultation-2014-10-21-glyceryl-trinitrate-and-azathioprine/